MAP kinase phosphatase 2 deficient mice develop attenuated experimental autoimmune encephalomyelitis through regulating dendritic cells and T cells

Por Barbour, Mark, Plevin, Robin, Jiang, Hui-Rong
Publicado no Sci Rep (2016)

Emerging role of interleukin-33 in autoimmune diseases

Por Pei, Cheng, Barbour, Mark, Fairlie-Clarke, Karen J, Allan, Debbie, Mu, Rong, Jiang, Hui-Rong
Publicado em 2014

Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches

Por Wood, Rachel A., Barbour, Mark J., Gould, Gwyn W., Cunningham, Margaret R., Plevin, Robin J.
Publicado no Pharmacol Res Perspect (2017)

Effect of sphingosine kinase modulators on interleukin‐1β release, sphingosine 1‐phosphate receptor 1 expression and experimental autoimmune encephalomyelitis

Por Barbour, Mark, McNaughton, Melissa, Boomkamp, Stephanie D, MacRitchie, Neil, Jiang, Hui‐Rong, Pyne, Nigel J, Pyne, Susan
Publicado no Br J Pharmacol (2016)

Interleukin‐33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways

Por Tong, Xiaoguang, Barbour, Mark, Hou, Kezuo, Gao, Chao, Cao, Shuang, Zheng, Jingli, Zhao, Yang, Mu, Rong, Jiang, Hui-Rong
Publicado no Mol Oncol (2015)

IL-33 attenuates the development of experimental autoimmune uveitis

Por Barbour, Mark, Allan, Debbie, Xu, Heping, Pei, Cheng, Chen, Mei, Niedbala, Wanda, Fukada, Sandra Y, Besnard, Anne-Galle, Alves-Filho, Jose C, Tong, Xiaoguang, Forrester, John V, Liew, Foo Yew, Jiang, Hui-Rong
Publicado no Eur J Immunol (2014)